Sammy Karam - 03 Aug 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: SENIOR VICE PRESIDENT
Signature: /s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact
Issuer symbol: ABT
Transactions as of: 03 Aug 2021
Net transactions value: -$372,800
Form type: 4
Filing time: 05 Aug 2021, 17:40:38 UTC
Next filing: 19 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$607,200	+8,000	+35%	$75.90	30,926	03 Aug 2021	Direct
transaction	ABT	Common shares without par value	Sale	$980,000	-8,000	-26%	$122.50	22,926	03 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-8,000	-11%	$0.000000	64,978	03 Aug 2021	Common Shares	8,000	$75.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.